Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues.
about
The use of psychotropic medication during pregnancy: how about the newborn?Recognizing and treating peripartum depressionAntidepressant medication during pregnancy and epigenetic changes in umbilical cord blood: a systematic reviewMethodological challenges in using routinely collected health data to investigate long-term effects of medication use during pregnancy.Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapyExposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy.Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates.Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and disorganized infant-mother attachment.The safety of escitalopram during pregnancy and breastfeeding: a comprehensive review.Prenatal Antidepressant Exposure and Childhood Autism Spectrum Disorders: Cause for Concern?Association between CYP2D6 Genotypes and the Risk of Antidepressant Discontinuation, Dosage Modification and the Occurrence of Maternal Depression during Pregnancy.Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort.Antidepressant Use in Late Gestation and Breastfeeding Rates at Discharge from Hospital.Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants.Prenatal exposure to selective serotonin reuptake inhibitors and risk of childhood overweight.
P2860
Q24625025-D8C625A4-E042-4047-9E1A-10E299BFCD11Q27013054-46224FED-D3BB-4539-A6D3-04673D9AF32BQ28075452-C84EF7A4-8890-4958-85C9-5C99D3C959C7Q30840124-B93D568A-F213-403D-8AE3-3147A92C15E1Q33745085-21814EB2-C06B-4174-8FDC-34E65EBD9D88Q34073546-45C508DA-01F5-4158-BB59-DB1716BC3304Q36213523-7352E494-233F-4886-AE79-DF3FCA4489BBQ36687640-5315836A-82FD-4CB4-B2BE-59229940F6D8Q38050322-34DA9CCB-3655-4410-B0C4-820E31AEA321Q38532482-C60B0AD3-5E90-44BB-A666-0F2052BE2871Q38645670-824AFFC5-D488-4F94-A316-9C91B0E0C8C9Q40535696-EAAC091E-2A89-45B2-A883-CCE15C772063Q47851526-99228E41-2AA8-4F1F-AF48-C17AB8EDC48EQ49494105-AA35131A-79FE-46C2-95AF-24A3CE3AA35BQ51321838-AF74E077-74BC-402F-BCD7-B58325495BD7
P2860
Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Investigating outcomes followi ...... ocus on methodological issues.
@en
Investigating outcomes followi ...... ocus on methodological issues.
@nl
type
label
Investigating outcomes followi ...... ocus on methodological issues.
@en
Investigating outcomes followi ...... ocus on methodological issues.
@nl
prefLabel
Investigating outcomes followi ...... ocus on methodological issues.
@en
Investigating outcomes followi ...... ocus on methodological issues.
@nl
P2093
P2860
P1433
P1476
Investigating outcomes followi ...... ocus on methodological issues.
@en
P2093
Andrew L Gilbert
Janna L Morrison
Luke E Grzeskowiak
P2860
P304
P356
10.2165/11593130-000000000-00000
P577
2011-11-01T00:00:00Z
P6179
1034482669